alternative / integrative
Hyperbaric Oxygen Therapy (peri-transplant)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-06-03 — Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant: Early-phase trial launched evaluating HBOT safety and impact on engraftment, GVHD, neutrophil recovery, and mucositis in patients with CMML, CNL, myelofibrosis, and MDS/MPN overlap undergoing allogeneic PBSC transplant — first-in-class peri-transplant application of HBOT in myeloid malignancies. (novelty: 4)
Open questions
Related
Contributing findings
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
03-jun-2026
novelty 4
per-area 4
introduces